These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 30165480)

  • 1. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
    He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
    Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hypertrophy effect of atorvastatin on myocardium depends on AMPK activation-induced miR-143-3p suppression via Foxo1.
    Yu B; Liu D; Zhang H; Xie D; Nie W; Shi K; Yang P
    Biomed Pharmacother; 2018 Oct; 106():1390-1395. PubMed ID: 30119211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
    Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin induction of heat shock factor 1 activation and the mitochondrial unfolded protein response alleviate cardiac remodeling in spontaneously hypertensive rats.
    Xu M; Li LP; He X; Lu XZ; Bi XY; Li Q; Xue XR
    FASEB J; 2024 May; 38(9):e23654. PubMed ID: 38717442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism.
    Huang R; Cui YC; Wei XH; Pan CS; Li Q; He SY; Fan JY; Han JY
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1378-H1388. PubMed ID: 30951366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.
    Wu QQ; Xu M; Yuan Y; Li FF; Yang Z; Liu Y; Zhou MQ; Bian ZY; Deng W; Gao L; Li H; Tang QZ
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1143-54. PubMed ID: 25713304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis.
    Ma H; Yu S; Liu X; Zhang Y; Fakadej T; Liu Z; Yin C; Shen W; Locasale JW; Taylor JM; Qian L; Liu J
    Circulation; 2019 Apr; 139(14):1725-1740. PubMed ID: 30636447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury.
    Xin T; Lu C
    Aging (Albany NY); 2020 Jul; 12(16):16224-16237. PubMed ID: 32721927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
    Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
    Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.
    Li J; Minćzuk K; Massey JC; Howell NL; Roy RJ; Paul S; Patrie JT; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
    J Am Heart Assoc; 2020 Apr; 9(7):e015154. PubMed ID: 32248762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
    Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
    Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
    You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
    Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
    Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
    Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of circadian disruption and calcium-handling protein defects by choline alleviates cardiac remodeling in abdominal aorta coarctation rats.
    He X; Yang S; Deng J; Wu Q; Zang WJ
    Lab Invest; 2021 Jul; 101(7):878-896. PubMed ID: 33649466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.